ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Aspida Life Re Ltd. Appoints Elinor Friedman to its Board of Directors

HAMILTON, Bermuda, March 26, 2025 (GLOBE NEWSWIRE) -- Aspida Life Re Ltd. (“Aspida Re”), a reinsurance company focused on providing life and annuity reinsurance solutions to companies globally, announced today the recent appointment of Elinor Friedman, FSA, MAAA to its Board of Directors (“the Board”). Ms. Friedman’s extensive product development and pricing knowledge will complement and add broader insight to Aspida Re’s board composition.

Ms. Friedman is a seasoned actuary with vast experience in the life insurance and reinsurance space. From 2013 to 2024, she served as Managing Director at Willis Towers Watson where she provided consulting services to large and mid-size insurers and reinsurers including sell-side appraisal, buy-side due diligence, product development, and pricing.

"Elinor's deep capabilities in actuarial science, risk management, and insurance analytics, combined with her proven leadership in insurance consulting, make her a valuable addition to our board," said David Florian, Chief Executive Officer of Aspida Re. "Her insights and operational acumen will be instrumental in helping Aspida Re continue to deliver ongoing value for our partners and clients."

During her time as Managing Director at Willis Towers Watson, Ms. Friedman also served as Life Division Leader and Sales and Practice Leader for the Americas leadership team for the Insurance Consulting and Technology (ICT) line of business. Prior to joining the firm, she served as Product Actuary at General American Life Insurance Company, coordinating life product development and pricing, and as Assistant Actuary at RGA/Swiss Financial Group, focused on reinsurance transactions, actuarial pricing, and risk analysis.

"I am excited to join Aspida Re’s board and contribute to the company’s mission of providing innovative and secure reinsurance solutions," said Elinor Friedman. "Aspida Re’s focus on risk management excellence and forward-thinking strategies aligns with my experience in actuarial science and insurance consulting. I look forward to leveraging my background to support Aspida Re’s growth, helping to refine reinsurance structures and strengthen partnerships that drive long-term financial security.”

Ms. Friedman received her Bachelor of Science in Applied Mathematics from Concordia University (with distinction) and her Master of Science in Applied Mathematics from the University of Ottawa (magna cum laude). She is a Fellow of the Society of Actuaries (FSA) and a Member of the American Academy of Actuaries (MAAA). Ms. Friedman is also active in the industry, having previously served as Chair of the Society of Actuaries Product Development Section Council and on the planning committee for several industry meetings. She has been a frequent speaker, lending her knowledge and expertise to the industry.

About Aspida Re
Aspida Life Re Ltd (“Aspida Re”), a Bermuda-based reinsurance platform, is focused on providing efficient and secure life and annuity reinsurance solutions to its global clients. Aspida Re seeks to be a trusted partner in its clients’ long-term financial growth by delivering creative, customized solutions while driving business by doing good for the communities it serves. Aspida Re is part of Aspida Holdings Ltd, with over $21bn in total assets as of December 31, 2024. A subsidiary of Ares Management Corporation (NYSE: ARES) acts as the dedicated investment manager, capital solutions and corporate development partner to Aspida Re. For more information on Aspida Re, please visit www.aspidare.bm or follow them on LinkedIn.

Media Contact:
Blaire Swayze
Blaire.swayze@aspida.com
+1-919-246-3108

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c8c0180c-cfc6-4036-bde7-bd8c9365073f


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.